These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 32842556)
21. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss. Alam G; Edler M; Burchfield S; Richardson JR Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118 [TBL] [Abstract][Full Text] [Related]
22. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317 [TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Matheus FC; Aguiar AS; Castro AA; Villarinho JG; Ferreira J; Figueiredo CP; Walz R; Santos AR; Tasca CI; Prediger RD Behav Brain Res; 2012 Dec; 235(2):263-72. PubMed ID: 22921927 [TBL] [Abstract][Full Text] [Related]
24. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234 [TBL] [Abstract][Full Text] [Related]
25. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model. Zhang Y; Qin L; Xie J; Li J; Wang C Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269 [TBL] [Abstract][Full Text] [Related]
26. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats. Lee EY; Lee JE; Park JH; Shin IC; Koh HC Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585 [TBL] [Abstract][Full Text] [Related]
27. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP Luo D; Zhao J; Cheng Y; Lee SM; Rong J Mol Neurobiol; 2018 Mar; 55(3):2258-2267. PubMed ID: 28321769 [TBL] [Abstract][Full Text] [Related]
28. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease. Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease. Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934 [TBL] [Abstract][Full Text] [Related]
30. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease. Jalewa J; Sharma MK; Gengler S; Hölscher C Neuropharmacology; 2017 May; 117():238-248. PubMed ID: 28223210 [TBL] [Abstract][Full Text] [Related]
31. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease. Castro AA; Wiemes BP; Matheus FC; Lapa FR; Viola GG; Santos AR; Tasca CI; Prediger RD Brain Res; 2013 Jun; 1513():103-16. PubMed ID: 23548600 [TBL] [Abstract][Full Text] [Related]
32. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease. Jarras H; Bourque M; Poirier AA; Morissette M; Coulombe K; Di Paolo T; Soulet D J Neuroendocrinol; 2020 Jan; 32(1):e12782. PubMed ID: 31430407 [TBL] [Abstract][Full Text] [Related]
33. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents. Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118 [TBL] [Abstract][Full Text] [Related]
34. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways. He H; Wang S; Tian J; Chen L; Zhang W; Zhao J; Tang H; Zhang X; Chen J Eur J Pharmacol; 2015 Nov; 767():175-82. PubMed ID: 26477638 [TBL] [Abstract][Full Text] [Related]
35. Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease. Pain S; Gochard A; Bodard S; Gulhan Z; Prunier-Aesch C; Chalon S Exp Toxicol Pathol; 2013 Jul; 65(5):689-94. PubMed ID: 23083629 [TBL] [Abstract][Full Text] [Related]
36. Up-regulation of autophagy-related gene 5 ( Hu ZY; Chen B; Zhang JP; Ma YY J Biol Chem; 2017 Nov; 292(44):18062-18074. PubMed ID: 28928221 [TBL] [Abstract][Full Text] [Related]
37. Methylene Blue Ameliorates Olfactory Dysfunction and Motor Deficits in a Chronic MPTP/Probenecid Mouse Model of Parkinson's Disease. Biju KC; Evans RC; Shrestha K; Carlisle DCB; Gelfond J; Clark RA Neuroscience; 2018 Jun; 380():111-122. PubMed ID: 29684508 [TBL] [Abstract][Full Text] [Related]
39. Oligo-Porphyran Ameliorates Neurobehavioral Deficits in Parkinsonian Mice by Regulating the PI3K/Akt/Bcl-2 Pathway. Liu Y; Geng L; Zhang J; Wang J; Zhang Q; Duan D; Zhang Q Mar Drugs; 2018 Mar; 16(3):. PubMed ID: 29509717 [TBL] [Abstract][Full Text] [Related]
40. Nicotine improved the olfactory impairment in MPTP-induced mouse model of Parkinson's disease. Yang J; Lv DJ; Li LX; Wang YL; Qi D; Chen J; Mao CJ; Wang F; Liu Y; Hu LF; Liu CF Neurotoxicology; 2019 Jul; 73():175-182. PubMed ID: 30978411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]